The sellers never planned on owning the 30.7-acre property in Lyme, but bought it after a boat deal fell through. Now it’s ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
Morgan Stanley has recently raised Gilead Sciences Inc (GILD) stock rating, as announced on January 10, 2025, according to Finviz. Earlier, on December 10, 2024, BofA Securities had resumed the stock ...
Hosted on MSN11h
Earnings Preview: What to Expect From Gilead Sciences’ ReportSituated in Foster City, California, Gilead Sciences, Inc. (GILD) is a top biopharmaceutical company specializing in the ...
GlobalData on MSN11h
FDA beats EMA to most approved new drugs in 2024The US Food and Drug Administration (FDA) has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs ...
Poor mental health was increasingly prevalent from 2011 to 2022, with inequities discernible by age, sex, and racial and ...
Piper Sandler analyst Joseph Catanzaro maintained a Buy rating on Keros Therapeutics (KROS – Research Report) today and set a price target of ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
The search is on for a suspect who Huntersville Police said shoved an elderly man and stole his vehicle at a local gas ...
In a report released yesterday, Jasper Hellweg from Argus Research maintained a Buy rating on Novo Nordisk (NVO – Research Report). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback